Independence over endorsement
Editorial ratings are independent of commission rate. We will publish a critical review of a partner that pays us if the facts warrant it.
Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
About GLP1Zoom
In 2026, choosing a GLP-1 telehealth provider means navigating 12+ partner offers across 50 state regulatory frameworks, with monthly prices that swing $200–800. Most comparisons online are commission tables in disguise. GLP1Zoom is built differently — independent reviewers, monthly price verification, and the rule that nothing about the score depends on how much we get paid.
By the numbers
The work behind every page you read. Counts refreshed quarterly.
Brand + compounded, verified monthly
GLP-1 × comorbidity safety pairs
Pharmacy + telehealth law per state
MD, PharmD, RD/CDCES, JD
Editorial mission
The first time someone shops for a GLP-1, they meet a market designed to confuse them. Brand vs compounded. Cash-pay vs insurance. 503A vs 503B pharmacies. Telehealth states that allow synchronous video but not asynchronous chat. A list price of $1,349 next to a coupon price of $499 next to a compounded vial at $199 — same active ingredient, wildly different regulatory weight.
We built GLP1Zoom to flatten that confusion into a decision a non-clinician can make with their doctor. Every partner we list is verified hands-on by an editor who signed up for the intake. Every clinical claim is cross-checked by a US-licensed reviewer before publication. Every price has a “Verified Xd ago” timestamp so you know how stale it is.
We make money when you sign up with a partner through us. We've made the editorial rules public on this page and on /methodology so you can hold us to them. If you ever spot a recommendation that smells like a commission rate dressed as advice, email [email protected] — every report gets investigated.
Editorial principles
Four principles, written down so we can be held to them.
Editorial ratings are independent of commission rate. We will publish a critical review of a partner that pays us if the facts warrant it.
Every price is verified monthly with the partner. Clinical claims cite the FDA prescribing information or a peer-reviewed trial.
We earn commission when you sign up with a partner. We do not run pharma display ads, sponsored content, or paid placements.
Medical and regulatory content is rewritten for a 9th-grade reading level without dropping accuracy. Sources cited at the bottom.
Editorial board
Every drug page is reviewed by a US-licensed clinician, pharmacist, or RD before publication. Editorial reviewers do not endorse any partner provider and have no commercial relationship with GLP1Zoom's affiliate revenue.
Board-Certified, Internal Medicine
Medical Reviewer — endocrine & metabolic content
Reviews diabetes and obesity content for clinical accuracy against current FDA labels.
Doctor of Pharmacy, MPH
Pharmacy Reviewer — drug interaction & dosing content
Verifies dose titration schedules, drug interactions, and pharmacy-related claims.
Registered Dietitian, Certified Diabetes Educator
Nutrition Reviewer — lifestyle & adherence content
Reviews diet, lifestyle, and patient-adherence guidance accompanying medication content.
Health Law, JD
Regulatory Reviewer — FDA, FTC, state pharmacy law
Cross-checks FDA approval status, state pharmacy practice rules, and compliance disclosures.
Reviewers are independent contractors paid a flat editorial fee — not commission. See our Editorial Policy · Medical Review Board.
Methodology
How we score partners →
Editorial policy
Our review process →
Medical Review Board
Reviewer credentials →
Editorial standards